A rare cancer once thought to be the stuff of medical trivia is now rising rapidly among younger adults. New research reveals that appendix cancer rates have quadrupled for older millennials compared to earlier generations, stirring both concern and confusion within the medical community.
The New Findings
A study led by Dr. Andreana Holowatyj, a clinical epidemiologist at Vanderbilt University Medical Center, has brought the alarming trend into sharp focus. Using data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program, the researchers tracked nearly 5,000 appendix cancer cases between 1975 and 2019.
Their findings, published in the Annals of Internal Medicine, show that while appendix cancer remains rare—affecting about one to two people per million each year—the incidence among people born between 1981 and 1989 has quadrupled compared to those born in the 1940s. Older millennials, in particular, face the steepest increase, with rates rising an average of 3.7 percent per year.
“This is concerning because it’s not just a fluke or an artifact of better detection,” said Holowatyj. “We’re seeing this across the board and in younger patients who often don’t know this disease even exists.”
What Might Be Causing the Rise?
Though the reasons behind this surge are not yet clear, experts believe that environmental and behavioral factors shared by those born in the same era—what scientists call a “birth cohort effect”—could be at play.
Dr. Ardaman Shergill, an oncologist at UChicago Medicine, suggested that obesity, poor diet, smoking, and alcohol use might contribute to the increase. “I suspect that strategies like healthier eating, limiting alcohol, and not smoking could have a protective effect for appendix cancer, just like they do for other GI cancers,” he said.
Holowatyj’s research has also found that more than one in ten appendix cancer patients carries a genetic mutation linked to cancer risk, raising the possibility of a hereditary component. Her team is now investigating these genetic links to see how they might interact with environmental factors.
Part of what makes appendix cancer so dangerous is how difficult it is to spot. Its symptoms—persistent abdominal pain, bloating, pelvic pain, and abdominal masses—can easily be mistaken for digestive troubles or gynecological issues.
A survey of 352 appendix cancer patients found that 77 percent experienced symptoms before being diagnosed, with many reporting symptoms for more than three months. Because colonoscopies rarely catch appendix tumors, and standard imaging techniques might miss them, nearly half of appendix cancers are diagnosed only after they’ve already spread.
“Younger adults are often less likely to undergo surgery for appendicitis, opting for antibiotics instead,” Holowatyj said. “But if there’s a tumor there, antibiotics won’t make it go away. This could delay a diagnosis that’s already hard to catch.”
A Broader Cancer Shift
The sharp increase in appendix cancer mirrors other trends in gastrointestinal cancers. Early-onset colorectal, stomach, and pancreatic cancers have all seen similar rises in young adults, hinting at shared risks that extend beyond the appendix.
“We need to understand if there are common exposures or dietary factors affecting the whole GI tract,” Holowatyj said. “Or if these cancers are rising for different reasons.”
The findings have led to a push for greater awareness and more research. The Appendiceal Cancer Consortium, an international collaboration, is now working to pinpoint environmental and lifestyle factors—like early-life diet and inflammation—that might be driving the surge.
“Appendix cancer is still rare,” Holowatyj said. “But the numbers are going up, and we need to get it on people’s radar. If something feels off—don’t ignore it.”
For those at risk, there’s no established screening test or prevention plan. Doctors advise paying attention to vague but persistent symptoms like abdominal pain, bloating, or fatigue. Surgery remains the main treatment, often followed by chemotherapy for more advanced cases. Survival rates vary widely, from 67 to 97 percent for early-stage disease, but dropping to as low as 10 percent for more advanced cancers.
As Dr. Zachary Brown of NYU Grossman Long Island School of Medicine put it, “There’s still so much to learn. We need better understanding of the tumor biology and molecular characteristics to create more targeted therapies and maybe even catch this cancer earlier in the future.”
While there’s no guaranteed way to prevent appendix cancer, staying alert to symptoms and seeking medical care when something seems amiss can make a difference. Adopting healthier habits—eating a balanced diet, exercising regularly, avoiding smoking and heavy drinking—might help lower overall cancer risk, including for the appendix.
For now, the best advice for millennials and others is to trust their instincts. As Holowatyj told her peers, “If something feels off, say something. It’s better to check and be wrong than to wait and be diagnosed late.”
